结肠直肠癌幸存者多种原发性癌症的危险因素
Mulugeta Melku1,2, Oliver G Best1, Jean M Winter1
1Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia.
Cancers
|July 12, 2025
概括
大肠直肠癌幸存者患后续癌症的风险更高. 男性性别,年龄较大,早期癌症和失调修复蛋白表达的损失是这些多种原发性癌症的关键风险因素.
科学领域:
- 在瘤学瘤学.
- 癌症流行病学 癌症流行病学
背景情况:
- 大肠直肠癌 (CRC) 是全球癌症相关死亡的主要原因.
- 经过CRC的幸存者面临着患上随后多种原发性癌症 (MPC) 的风险增加.
研究的目的:
- 在CRC幸存者中确定甲时MPC的发病率.
- 为了确定与这群人群中MPCs发展相关的风险因素.
主要方法:
- 在2011年至2024年期间诊断出554名CRC患者的回顾性分析.
- 利用累积发病率函数和分分布危险模型.
- 收集的社会人口统计,临床,瘤和治疗数据.
主要成果:
- 12%的CRC幸存者在5年的中位数随访期内发展出MPC.
- 累计MPC发病率为20.9%;标准化发病率 (SIR) 为1.32.
- 与男性性别,年龄超过65岁,早期癌症和不匹配修复 (MMR) 蛋白表达损失相关的风险增加.
结论:
- 与一般人群相比,CRC幸存者患MPC的风险较高.
- 识别诸如性别,年龄,癌症阶段和MMR状态等危险因素至关重要.
- 建议采用个性化监测策略,以提前发现并改善结果.
相关概念视频
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
12.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.9K
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


